Firas Petros, MD, FACS
UTMC: 419.383.6644; Regency: 419.473.3446
American Board of Urology
Al-Nahrain University / College of Medicine, Baghdad, Iraq.
Internship and Urology Residency, The Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute. Columbus, Ohio.
Urologic Oncology Fellowship, Department of Urology at The University of Texas MD Anderson Cancer Center. Houston, Texas.
Research and Clinical Fellowships in Robotic and Minimally Invasive Urologic Surgery, Vattikuti Urology Institute at Henry Ford Hospital, Detroit, Michigan.
Urologic Cancers including Prostate, Kidney and Adrenal, Upper Urinary Tract Cancers including Renal Pelvis and Ureteral Cancers, Bladder and Urethral Cancers, Testicular and Penile Cancers.
Open and Minimally Invasive Surgical Procedures including Endoscopy, Laparoscopy and Robotics.
Active Surveillance Programs for low risk Prostate Cancer and Small Renal Masses and Treatment of Urologic Diseases.
My primary research focuses on two disease entities Upper Tract Urothelial Carcinoma (UTUC) and Renal Cell Carcinoma (RCC). Specifically, translational research involving genomic profiling of UTUC and gene expression analysis of same-patient metachronous UTUC and bladder cancer. Furthermore, other areas of research include clinical research in UTUC and RCC studying disease stratification, surgical outcomes and complications.
1. Best Poster Award for an abstract on “Genomic Analysis of
Same-Patient Metachronous Upper-Tract and Bladder Urothelial Carcinoma”, AUA Annual Meeting, San Francisco, CA. 5/2018
2. Best Winning Poster (3rd place award) for an abstract on “Genomic Analysis of Same-Patient Metachronous Upper-Tract and Bladder Urothelial Carcinoma”, 18th Annual Meeting of the Society of Urologic Oncology. Washington, DC. 11/2017
3. AUA Take Home Message and Highlight Selection at the Society of Urologic Robotic Surgery (SURS) for abstract on “Oncologic Outcomes of Patients with Positive Surgical Margin after Partial Nephrectomy: A 25-Year Single Institution Experience”, AUA Annual Meeting, Boston, MA. 5/2017
4. Best Scientific Paper Presentation Award at the ECR meeting for an abstract in oncologic imaging on “The feasibility of k-means clustering of dynamic contrast-enhanced MRI pharmacokinetic parameters in predicting prostate cancer risk stratification”, Vienna, Austria. 3/2016
5. Best Winning Video Award for a video on “Management of
Venous Tumor Thrombus Encountered During Robot-assisted Partial Nephrectomy for Renal Cell Carcinoma”, AUA North-Central Section 89th Annual Meeting, Amelia Island, Fl. 11/2015
Dr. Petros is a member of the American Urological Association, the Society of Urologic Oncology, the American College of Surgeons, and the American Medical Association. He serves as a reviewer for multiple journals, including Journal of Urology, Urologic Oncology, BJU International, Urology, BMC Cancer and Journal of Endourology, among others.
To view additional publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=firas+Petros
Assistant Professor of Urology
Chief of Urologic Oncology
Frank Stranahan Endowed Chair
Northwest Ohio Location(s)
Eleanor N. Dana Cancer Center
2920 Transverse Drive
Parking Information and Directions
Medical Pavilion
1125 Hospital Dr. Toledo,OH 43614
Parking Information and Directions
Regency Medical Campus
1000 Regency Court
Toledo, OH 43623
Parking Information and Directions
Urology Home Page
Oncology Home Page